Vaccines and variants: an update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19.
作者信息
O'Sullivan Oliver, Rienks Rienk, Holdsworth David, Davos Constantinos H, Halle Martin, Bennett Alexander, Parati Gianfranco, Guettler Norbert, Nicol Edward
机构信息
Academic Department of Military Rehabilitation, Defence Medical Rehabilitation Centre, Stanford Hall, Stanford on Soar, Loughborough LE12 5QN, UK.
School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
出版信息
Eur J Prev Cardiol. 2023 Jan 24;30(2):177-179. doi: 10.1093/eurjpc/zwac228.
Abstract
摘要
相似文献
1
Vaccines and variants: an update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19.疫苗与变体：COVID-19 后重返高风险职业前心肺评估的最新情况
Eur J Prev Cardiol. 2023 Jan 24;30(2):177-179. doi: 10.1093/eurjpc/zwac228.
2
Correction to: Vaccines and variants: an update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19.对《疫苗与变体：COVID-19后重返高风险职业前心肺评估的最新情况》的更正
Eur J Prev Cardiol. 2024 Oct 10;31(14):e109. doi: 10.1093/eurjpc/zwad382.
3
Cardiopulmonary assessment prior to returning to high-hazard occupations post-symptomatic COVID-19 infection: a position statement of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology.新冠病毒感染后返回高风险职业前的心肺评估：欧洲预防心脏病学协会航空和职业心脏病学工作组的立场声明。
Eur J Prev Cardiol. 2022 Oct 18;29(13):1724-1730. doi: 10.1093/eurjpc/zwac041.
4
Return to high-hazard occupations after COVID-19 infection: a cardiopulmonary assessment approach.新冠病毒感染后重返高风险职业：一种心肺评估方法
Eur J Prev Cardiol. 2022 Oct 18;29(13):1721-1723. doi: 10.1093/eurjpc/zwac072.
5
COVID-19 vaccines: concerns beyond protective efficacy and safety.COVID-19 疫苗：除了保护效力和安全性之外的关注点。
Expert Rev Vaccines. 2021 Aug;20(8):1013-1025. doi: 10.1080/14760584.2021.1949293. Epub 2021 Jul 5.
6
Immunogenicity, efficacy and safety of COVID-19 vaccines: an update of data published by 31 December 2021.COVID-19 疫苗的免疫原性、疗效和安全性：截至 2021 年 12 月 31 日已发表数据的更新。
Int Immunol. 2022 Dec 31;34(12):595-607. doi: 10.1093/intimm/dxac031.
7
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.BNT162b2 疫苗和 mRNA-1273 新冠疫苗在预防医护人员、第一响应者和其他必要及一线工作人员感染 SARS-CoV-2 中的疫苗有效性的临时估计-2020 年 12 月至 2021 年 3 月美国 8 个地点。
MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):495-500. doi: 10.15585/mmwr.mm7013e3.
8
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2.关于 COVID-19 疫苗对 SARS-CoV-2 不同变体有效性的最新信息。
Int Immunopharmacol. 2023 Apr;117:109968. doi: 10.1016/j.intimp.2023.109968. Epub 2023 Mar 2.
9
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.SARS-CoV-2 变体和 COVID-19 疫苗：当前的挑战与未来策略。
Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28.
10
Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.决定是否以及如何更新新冠疫苗以预防变异毒株所面临的挑战。
JAMA. 2022 Jun 21;327(23):2273-2275. doi: 10.1001/jama.2022.9367.
引用本文的文献
1
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study.一项队列研究中SARS-CoV-2感染后自我报告的体能下降及疫苗加强针的影响
Open Forum Infect Dis. 2023 Nov 17;10(12):ofad579. doi: 10.1093/ofid/ofad579. eCollection 2023 Dec.
2
Cardiopulmonary, Functional, Cognitive and Mental Health Outcomes Post-COVID-19, Across the Range of Severity of Acute Illness, in a Physically Active, Working-Age Population.新冠疫情后，在身体活跃的工作年龄人群中，急性疾病严重程度各异时的心肺、功能、认知及心理健康结果
Sports Med Open. 2023 Feb 2;9(1):7. doi: 10.1186/s40798-023-00552-0.
Zotero 插件